RT Journal Article
T1 [Health-related quality of life in patients consuming benzodiazepine].
T2 Calidad de vida relacionada con la salud en pacientes consumidores de benzodiacepinas.
A1 García Atienza, Eva María
A1 López-Torres Hidalgo, Jesús
A1 Minuesa García, María
A1 Ruipérez Moreno, María
A1 Lucas Galán, Francisco Javier
A1 Agudo Mena, José Luis
K1 Benzodiacepinas
K1 Benzodiazepines
K1 Calidad de vida relacionada con la salud
K1 EQ-5D
K1 Estado de salud percibido
K1 Health-related quality of life
K1 Perceived state of health
AB To describe the health-related quality of life (HRQoL) in benzodiazepine users and to verify whether there is an association with the characteristics of the treatment, its effectiveness, and the sociodemographic variables. Descriptive cross-sectional study. Family medicine consultations. Four hundred and fifty 2patients over 18 years of age consuming benzodiazepines or similar drugs. HRQoL was assessed using the EuroQol5-D questionnaire. Other variables: symptoms of anxiety or insomnia, sociodemographic variables and characteristics of the treatment. The mean score in health status was 62.80 (95% CI: 60.69-64.86), lower in people without studies (59.27±21.97 SD; P=.004) and lower social category (60.02±21.27 SD; P Patients who use benzodiazepines show, despite treatment, a moderate HRQL, lower than that obtained in the general population or in primary care patients. The situation is more favorable in the youngest, in those who do not present anxiety/insomnia, in those belonging to higher social classes and when the consumption of drugs is lower.
YR 2021
FD 2021-03-26
LK http://hdl.handle.net/10668/17420
UL http://hdl.handle.net/10668/17420
LA es
DS RISalud
RD Apr 20, 2025